메뉴 건너뛰기




Volumn 23, Issue 3, 2005, Pages 402-403

Successful therapy of bosentan-refractory pulmonary arterial hypertension (PAH) with inhalative iloprost

Author keywords

Dual endothelin receptor antagonist bosentan; Inhaled iloprost; Pulmonary arterial hypertension (PAH)

Indexed keywords

BOSENTAN; CALCIUM ANTAGONIST; ILOPROST;

EID: 20444486938     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (8)
  • 1
    • 0035818316 scopus 로고    scopus 로고
    • Effects of the dual endothelin-receptor antagoniste bosentan in patients with pulmonary hypertension: A randomised placebo-controlled study
    • CHANNICK RN, SIMONNEAU G, SITBON O et al.: Effects of the dual endothelin-receptor antagoniste bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 2001; 358: 1119-23.
    • (2001) Lancet , vol.358 , pp. 1119-1123
    • Channick, R.N.1    Simonneau, G.2    Sitbon, O.3
  • 2
    • 0037149718 scopus 로고    scopus 로고
    • Bosentan therapy for pulmonary arterial hypertension
    • RUBIN LJ, BADESCH DB, BARST RJ et al.: Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903.
    • (2002) N. Engl. J. Med. , vol.346 , pp. 896-903
    • Rubin, L.J.1    Badesch, D.B.2    Barst, R.J.3
  • 4
    • 0034702248 scopus 로고    scopus 로고
    • Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
    • HOEPER MM, SCHWARZE M, EHLERDING S et al.: Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med 2000; 342: 1866-1870.
    • (2000) N. Engl. J. Med. , vol.342 , pp. 1866-1870
    • Hoeper, M.M.1    Schwarze, M.2    Ehlerding, S.3
  • 5
    • 0036682273 scopus 로고    scopus 로고
    • Inhaled iloprost for severe pulmonary hypertension
    • OLSCHEWSKI H, SIMONNEAU G, GALIE N et al.: Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002; 347: 322-9.
    • (2002) N. Engl. J. Med. , vol.347 , pp. 322-329
    • Olschewski, H.1    Simonneau, G.2    Galie, N.3
  • 6
    • 0032578279 scopus 로고    scopus 로고
    • Primary pulmonary hypertension
    • GAINE SP, RUBIN LJ: Primary pulmonary hypertension. Lancet 1998; 352: 719-25.
    • (1998) Lancet , vol.352 , pp. 719-725
    • Gaine, S.P.1    Rubin, L.J.2
  • 7
    • 17144452827 scopus 로고    scopus 로고
    • Continuous intravenous epoprostenol for pulmonary hypertension due to scleroderma spectrum of disease
    • BADESCH DB, TAPSON VF, McGOON MD et al.: Continuous intravenous epoprostenol for pulmonary hypertension due to scleroderma spectrum of disease. Ann Intern Med 2000; 132: 425-434.
    • (2000) Ann. Intern. Med. , vol.132 , pp. 425-434
    • Badesch, D.B.1    Tapson, V.F.2    Mcgoon, M.D.3
  • 8
    • 0034953832 scopus 로고    scopus 로고
    • Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients
    • STRATTON R, SHIWEN X, MARTINI G, HOLMES A, LEASK A, HABERBERGER T: Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J Clin Invest 2001; 108: 241-250.
    • (2001) J. Clin. Invest. , vol.108 , pp. 241-250
    • Stratton, R.1    Shiwen, X.2    Martini, G.3    Holmes, A.4    Leask, A.5    Haberberger, T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.